Conclusions
CHD
NT-proBNP is closely related to the risk of CAP formation in different glucose metabolic states in patients with CHD. This relationship was especially significant in males and those > 60 years old, in men with pre-DM, and in patients > 60 years old with pre-DM and DM status. High NT-proBNP levels were strongly associated with high echogenicity and multiple CAPs. In patients with CHD and abnormal glucose metabolism, clinicians should monitor for elevated NT-proBNP levels and consider its association with CAP.